Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05275556 · ClinicalTrials.gov registry record · NA
Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study)
A NA study, sponsored by Verily Life Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,410
- Enrollment target
NCT05275556: Completed NA study, sponsored by Verily Life Sciences.
NCT05275556 is a NA study that has completed, run by Verily Life Sciences. The registered enrollment target is 1,410 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05275556, a NA study, has completed, sponsored by Verily Life Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,410 participants
- Enrollment target
Study Summary
This is a prospective, multicenter, randomized controlled study to evaluate the effect of the Computer-Assisted Detection (CADe) Device on Adenomas Per Colonoscopy and Positive Percent Agreement for routine colonoscopies. The control arm is colonoscopy performed with High Definition White Light Endoscopy (HD-WLE) per standard of care. The intervention arm is colonoscopy performed with HD-WLE per standard of care plus the Computer-Assisted Detection (CADe) Device.
Primary Outcome
Difference in Adenomas Per Colonoscopy (APC) between the control and intervention arm, evaluated for superiority. APC is defined as the average number of histologically confirmed adenomas resected per colonoscopy.
Interventions
- DEVICE Computer-Assisted Detection (CADe) Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,410 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2022-10-28 |
| Phase | NA |
What the finished NCT05275556 record still lists
NCT05275556 is an interventional study that assigns participants to a tested intervention. Its 1,410 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 1 intervention - of which Computer-Assisted Detection (CADe) Device is the first listed.
NCT05275556 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05275556 about?
NCT05275556 is a clinical study titled "Gastroenterology Artificial INtelligence System for Detecting Colorectal Polyps (The GAIN Study)". This is a prospective, multicenter, randomized controlled study to evaluate the effect of the Computer-Assisted Detection (CADe) Device on Adenomas Per Colonoscopy and Positive Percent Agreement for routine colonoscopies. The control arm is colonoscopy performed with High Definition White Light Endo...
What is the current status of trial NCT05275556?
This trial is currently completed. It is a NA study. The enrollment target is 1,410 participants. The study started on 2022-03-01. Estimated completion is 2022-10-28.
What interventions are being tested in trial NCT05275556?
The interventions under investigation include: Computer-Assisted Detection (CADe) Device (DEVICE).
Who is sponsoring clinical trial NCT05275556?
This trial is sponsored by Verily Life Sciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05275556's enrollment target sits among peer trials
1,410 70th of 2000 higher than 1,930 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05890404 · 1,410 participants · NA
SGM Evidenced-Based Mental Healthcare Implementation
- NCT07042451 · 1,410 participants · NA
An Evaluation of the Pink Cloud Application in Post- Treatment Substance Use Disorder Support
- NCT07222566 · 1,410 participants · Phase 3
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- NCT05992935 · 1,405 participants · Phase 1
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI